HSBC Holdings
CLPT icon

HSBC Holdings’s ClearPoint Neuro CLPT Stock Holding History

HSBC Holdings’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,141
Closed -$129K – 2969
2026
Q1 		$129K Buy
+14,141
New +$179K ﹤0.01% 2714
2025
Q4 		– Sell
-31,616
Closed -$677K – 2970
2025
Q3 		$677K Buy
31,616
+14,992
+90% +$177K ﹤0.01% 1957
2025
Q2 		$199K Buy
+16,624
New +$209K ﹤0.01% 2680

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

HSBC Holdings's CLPT Position: Q2 2026 in Review

HSBC Holdings sold out of ClearPoint Neuro (CLPT) in Q2 2026, closing a stake of 14,141 shares — an estimated $129K sold.

HSBC Holdings first reported a position in CLPT in Q2 2025 and held it in 3 quarters. The position peaked at $677K in Q3 2025. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • HSBC Holdings reported no remaining ClearPoint Neuro position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 14,141 ClearPoint Neuro shares in Q2 2026, an estimated $129K.
  • HSBC Holdings first reported a position in ClearPoint Neuro in Q2 2025 and held it in 3 quarters.
  • HSBC Holdings's ClearPoint Neuro position peaked at $677K in Q3 2025.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.